[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2025 Global Hereditary Angioedema Drug Market Research by Type, End-Use and Region (COVID-19 Version)

August 2020 | 121 pages | ID: 2E502AB3B915EN
99Strategy

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

The global Hereditary Angioedema Drug market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:
  • Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
  • Chapter 2: Global Production & Consumption Market by Type and End-Use
  • Chapter 3: Europe Production & Consumption Market by Type and End-Use
  • Chapter 4: America Production & Consumption Market by Type and End-Use
  • Chapter 5: Asia Production & Consumption Market by Type and End-Use
  • Chapter 6: Oceania Production & Consumption Market by Type and End-Use
  • Chapter 7: Africa Production & Consumption Market by Type and End-Use
  • Chapter 8: Global Market Forecast by Type, End-Use and Region
  • Chapter 9: Company information, Sales, Cost, Margin, news etc.
  • Chapter 10: Market Competition by Companies and Market Concentration Ratio
  • Chapter 11: Market Impact by Coronavirus.
  • Chapter 12: Industry Summary
Market Segment as follows:

Key Companies
  • Pharming Group NV
  • Shire plc
  • CSL Limited
  • iBio Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.
Key Types
  • By Product
  • C1 Esterase Inhibitor
  • Kallikrein Inhibitor
  • Selective Bradykinin B2 Receptor Antagonist
  • By Route of Administration
  • Oral
  • Intravenous
  • Subcutaneous Injection
Key End-Use
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
This report can be dispatched within 24-48 Hours.
CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe Hereditary Angioedema Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Hereditary Angioedema Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America Hereditary Angioedema Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Hereditary Angioedema Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia Hereditary Angioedema Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaHereditary Angioedema Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania Hereditary Angioedema Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Hereditary Angioedema Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa Hereditary Angioedema Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Hereditary Angioedema Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global Hereditary Angioedema Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Hereditary Angioedema Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Hereditary Angioedema Drug Revenue by Type, 2015-2020 (Million USD)
Figure Global Hereditary Angioedema Drug Revenue Share by Type in 2020 (Million USD)
Table Global Hereditary Angioedema Drug Production Volume by Type, 2015-2020 (Volume)
Figure Global Hereditary Angioedema Drug Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Hereditary Angioedema Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Hereditary Angioedema Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Hereditary Angioedema Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Hereditary Angioedema Drug Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Hereditary Angioedema Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Hereditary Angioedema Drug Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe Hereditary Angioedema Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Hereditary Angioedema Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Hereditary Angioedema Drug Revenue by Type, 2015-2020 (Million USD)
Figure Europe Hereditary Angioedema Drug Revenue Share by Type in 2020 (Million USD)
Table Europe Hereditary Angioedema Drug Production Volume by Type, 2015-2020 (Volume)
Figure Europe Hereditary Angioedema Drug Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Hereditary Angioedema Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Hereditary Angioedema Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Hereditary Angioedema Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Hereditary Angioedema Drug Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Hereditary Angioedema Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Hereditary Angioedema Drug Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America Hereditary Angioedema Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Hereditary Angioedema Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Hereditary Angioedema Drug Revenue by Type, 2015-2020 (Million USD)
Figure America Hereditary Angioedema Drug Revenue Share by Type in 2020 (Million USD)
Table America Hereditary Angioedema Drug Production Volume by Type, 2015-2020 (Volume)
Figure America Hereditary Angioedema Drug Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Hereditary Angioedema Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Hereditary Angioedema Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table America Hereditary Angioedema Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Hereditary Angioedema Drug Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Hereditary Angioedema Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Hereditary Angioedema Drug Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia Hereditary Angioedema Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Hereditary Angioedema Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Hereditary Angioedema Drug Revenue by Type, 2015-2020 (Million USD)
Figure Asia Hereditary Angioedema Drug Revenue Share by Type in 2020 (Million USD)
Table Asia Hereditary Angioedema Drug Production Volume by Type, 2015-2020 (Volume)
Figure Asia Hereditary Angioedema Drug Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Hereditary Angioedema Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Hereditary Angioedema Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Hereditary Angioedema Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Hereditary Angioedema Drug Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Hereditary Angioedema Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Hereditary Angioedema Drug Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania Hereditary Angioedema Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Hereditary Angioedema Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Hereditary Angioedema Drug Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Hereditary Angioedema Drug Revenue Share by Type in 2020 (Million USD)
Table Oceania Hereditary Angioedema Drug Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Hereditary Angioedema Drug Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Hereditary Angioedema Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Hereditary Angioedema Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Hereditary Angioedema Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Hereditary Angioedema Drug Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Hereditary Angioedema Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Hereditary Angioedema Drug Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa Hereditary Angioedema Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Hereditary Angioedema Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Hereditary Angioedema Drug Revenue by Type, 2015-2020 (Million USD)
Figure Africa Hereditary Angioedema Drug Revenue Share by Type in 2020 (Million USD)
Table Africa Hereditary Angioedema Drug Production Volume by Type, 2015-2020 (Volume)
Figure Africa Hereditary Angioedema Drug Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Hereditary Angioedema Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Hereditary Angioedema Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Hereditary Angioedema Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Hereditary Angioedema Drug Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Hereditary Angioedema Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Hereditary Angioedema Drug Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global Hereditary Angioedema Drug Production Forecast
Figure Global Hereditary Angioedema Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Hereditary Angioedema Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Hereditary Angioedema Drug Forecast by Type
Table Global Hereditary Angioedema Drug Revenue by Type, 2020E-2025F (Million USD)
Figure Global Hereditary Angioedema Drug Revenue Share by Type in 2025 (Million USD)
Table Global Hereditary Angioedema Drug Production Volume by Type, 2020E-2025F (Volume)
Figure Global Hereditary Angioedema Drug Production Volume Share by Type in 2025 (Volume)
8.3 Global Hereditary Angioedema Drug Forecast by End-Use (2020E-2025F)
Table Global Hereditary Angioedema Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Hereditary Angioedema Drug Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Hereditary Angioedema Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Hereditary Angioedema Drug Forecast by Region (2020E-2025F)
Table Global Hereditary Angioedema Drug Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Hereditary Angioedema Drug Consumption Value Share by Region in 2025 (Million USD)
Table Global Hereditary Angioedema Drug Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Hereditary Angioedema Drug Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Pharming Group NV
  9.1.1 Pharming Group NV Profile
Table Pharming Group NV Overview List
  9.1.2 Pharming Group NV Products & Services
  9.1.3 Pharming Group NV Company Dynamics & News
  9.1.4 Pharming Group NV Business Operation Conditions
Table Business Operation of Pharming Group NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Shire plc
  9.2.1 Shire plc Profile
Table Shire plc Overview List
  9.2.2 Shire plc Products & Services
  9.2.3 Shire plc Company Dynamics & News
  9.2.4 Shire plc Business Operation Conditions
Table Business Operation of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 CSL Limited
  9.3.1 CSL Limited Profile
Table CSL Limited Overview List
  9.3.2 CSL Limited Products & Services
  9.3.3 CSL Limited Company Dynamics & News
  9.3.4 CSL Limited Business Operation Conditions
Table Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 iBio Inc.
  9.4.1 iBio Inc. Profile
Table iBio Inc. Overview List
  9.4.2 iBio Inc. Products & Services
  9.4.3 iBio Inc. Company Dynamics & News
  9.4.4 iBio Inc. Business Operation Conditions
Table Business Operation of iBio Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 BioCryst Pharmaceuticals, Inc.
  9.5.1 BioCryst Pharmaceuticals, Inc. Profile
Table BioCryst Pharmaceuticals, Inc. Overview List
  9.5.2 BioCryst Pharmaceuticals, Inc. Products & Services
  9.5.3 BioCryst Pharmaceuticals, Inc. Company Dynamics & News
  9.5.4 BioCryst Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of BioCryst Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Ionis Pharmaceuticals, Inc.
  9.6.1 Ionis Pharmaceuticals, Inc. Profile
Table Ionis Pharmaceuticals, Inc. Overview List
  9.6.2 Ionis Pharmaceuticals, Inc. Products & Services
  9.6.3 Ionis Pharmaceuticals, Inc. Company Dynamics & News
  9.6.4 Ionis Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Ionis Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global Hereditary Angioedema Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Hereditary Angioedema Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Hereditary Angioedema Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Hereditary Angioedema Drug Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Hereditary Angioedema Drug Market Concentration Ratio in 2020E
Figure America Hereditary Angioedema Drug Market Concentration Ratio in 2020E
Figure Asia Hereditary Angioedema Drug Market Concentration Ratio in 2020E
Figure Oceania Hereditary Angioedema Drug Market Concentration Ratio in 2020E
Figure Africa Hereditary Angioedema Drug Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON HEREDITARY ANGIOEDEMA DRUG INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 HEREDITARY ANGIOEDEMA DRUG INDUSTRY SUMMARY & CONCLUSION
LIST OF TABLES
Table Global Hereditary Angioedema Drug Revenue by Type, 2015-2020 (Million USD)
Table Global Hereditary Angioedema Drug Production Volume by Type, 2015-2020 (Volume)
Table Global Hereditary Angioedema Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Hereditary Angioedema Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Hereditary Angioedema Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Hereditary Angioedema Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Hereditary Angioedema Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Hereditary Angioedema Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Hereditary Angioedema Drug Revenue by Type, 2015-2020 (Million USD)
Table Europe Hereditary Angioedema Drug Production Volume by Type, 2015-2020 (Volume)
Table Europe Hereditary Angioedema Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Hereditary Angioedema Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Hereditary Angioedema Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Hereditary Angioedema Drug Consumption Volume by Region, 2015-2020 (Volume)
Table America Hereditary Angioedema Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Hereditary Angioedema Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Hereditary Angioedema Drug Revenue by Type, 2015-2020 (Million USD)
Table America Hereditary Angioedema Drug Production Volume by Type, 2015-2020 (Volume)
Table America Hereditary Angioedema Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Hereditary Angioedema Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Hereditary Angioedema Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Hereditary Angioedema Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Hereditary Angioedema Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Hereditary Angioedema Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Hereditary Angioedema Drug Revenue by Type, 2015-2020 (Million USD)
Table Asia Hereditary Angioedema Drug Production Volume by Type, 2015-2020 (Volume)
Table Asia Hereditary Angioedema Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Hereditary Angioedema Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Hereditary Angioedema Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Hereditary Angioedema Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Hereditary Angioedema Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Hereditary Angioedema Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Hereditary Angioedema Drug Revenue by Type, 2015-2020 (Million USD)
Table Oceania Hereditary Angioedema Drug Production Volume by Type, 2015-2020 (Volume)
Table Oceania Hereditary Angioedema Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Hereditary Angioedema Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Hereditary Angioedema Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Hereditary Angioedema Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Hereditary Angioedema Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Hereditary Angioedema Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Hereditary Angioedema Drug Revenue by Type, 2015-2020 (Million USD)
Table Africa Hereditary Angioedema Drug Production Volume by Type, 2015-2020 (Volume)
Table Africa Hereditary Angioedema Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Hereditary Angioedema Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Hereditary Angioedema Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Hereditary Angioedema Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Global Hereditary Angioedema Drug Revenue by Type, 2020E-2025F (Million USD)
Table Global Hereditary Angioedema Drug Production Volume by Type, 2020E-2025F (Volume)
Table Global Hereditary Angioedema Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Hereditary Angioedema Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Hereditary Angioedema Drug Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Hereditary Angioedema Drug Consumption Volume by Region, 2020E-2025F (Volume)
Table Pharming Group NV Overview List
Table Business Operation of Pharming Group NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shire plc Overview List
Table Business Operation of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSL Limited Overview List
Table Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table iBio Inc. Overview List
Table Business Operation of iBio Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioCryst Pharmaceuticals, Inc. Overview List
Table Business Operation of BioCryst Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ionis Pharmaceuticals, Inc. Overview List
Table Business Operation of Ionis Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Hereditary Angioedema Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Hereditary Angioedema Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Hereditary Angioedema Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Hereditary Angioedema Drug Sales Volume Share by Companies, 2015-2020E (Volume)
LIST OF FIGURES
Figure Europe Hereditary Angioedema Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Hereditary Angioedema Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Hereditary Angioedema Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Hereditary Angioedema Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Hereditary Angioedema Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaHereditary Angioedema Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Hereditary Angioedema Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Hereditary Angioedema Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Hereditary Angioedema Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Hereditary Angioedema Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Hereditary Angioedema Drug Revenue Share by Type in 2020 (Million USD)
Figure Global Hereditary Angioedema Drug Production Volume Share by Type in 2020 (Volume)
Figure Global Hereditary Angioedema Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Hereditary Angioedema Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Hereditary Angioedema Drug Revenue Share by Type in 2020 (Million USD)
Figure Europe Hereditary Angioedema Drug Production Volume Share by Type in 2020 (Volume)
Figure Europe Hereditary Angioedema Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Hereditary Angioedema Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Hereditary Angioedema Drug Revenue Share by Type in 2020 (Million USD)
Figure America Hereditary Angioedema Drug Production Volume Share by Type in 2020 (Volume)
Figure America Hereditary Angioedema Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Hereditary Angioedema Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Hereditary Angioedema Drug Revenue Share by Type in 2020 (Million USD)
Figure Asia Hereditary Angioedema Drug Production Volume Share by Type in 2020 (Volume)
Figure Asia Hereditary Angioedema Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Hereditary Angioedema Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Hereditary Angioedema Drug Revenue Share by Type in 2020 (Million USD)
Figure Oceania Hereditary Angioedema Drug Production Volume Share by Type in 2020 (Volume)
Figure Oceania Hereditary Angioedema Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Hereditary Angioedema Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Hereditary Angioedema Drug Revenue Share by Type in 2020 (Million USD)
Figure Africa Hereditary Angioedema Drug Production Volume Share by Type in 2020 (Volume)
Figure Africa Hereditary Angioedema Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Hereditary Angioedema Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Hereditary Angioedema Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Hereditary Angioedema Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Hereditary Angioedema Drug Revenue Share by Type in 2025 (Million USD)
Figure Global Hereditary Angioedema Drug Production Volume Share by Type in 2025 (Volume)
Figure Global Hereditary Angioedema Drug Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Hereditary Angioedema Drug Consumption Value Share by Region in 2025 (Million USD)
Figure Global Hereditary Angioedema Drug Consumption Volume Share by Region in 2025 (Volume)


More Publications